[A good combination to achieve a reduced number of fractures: bone density measurements, drug therapy and hip protector].
Johnell
O
O
Ortopediska kliniken, Universitetssjukhuset MAS, Malmö.
Ljunggren
O
O
Mellström
D
D
D000368:Aged; D015519:Bone Density; D002986:Clinical Trials as Topic; D004164:Diphosphonates / Q000008:administration & dosage; D005260:Female; D006620:Hip Fractures / Q000209:etiology / Q000517:prevention & control*; D006801:Humans; D008019:Life Style; D008297:Male; D010024:Osteoporosis / Q000150:complications / Q000188:drug therapy*; D015663:Osteoporosis, Postmenopausal / Q000150:complications / Q000188:drug therapy; D011482:Protective Devices; D016032:Randomized Controlled Trials as Topic; D012307:Risk Factors; D020845:Selective Estrogen Receptor Modulators / Q000008:administration & dosage
D004164:Diphosphonates; D020845:Selective Estrogen Receptor Modulators